GlobeStar Therapeutics Corporation
GSTC · OTC
9/30/2023 | 9/30/2022 | 9/30/2021 | 9/30/2020 | |
|---|---|---|---|---|
| Market Cap | $1,489 | $2,326 | $14,270 | $2,027 |
| - Cash | $0 | $6 | $6 | $81 |
| + Debt | $366 | $20 | $106 | $155 |
| Enterprise Value | $1,855 | $2,339 | $14,370 | $2,101 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | -100% | – |
| Gross Profit | $0 | $0 | -$2 | -$38 |
| % Margin | – | – | – | -48,837.7% |
| EBITDA | $7 | -$1,264 | -$9,093 | -$302 |
| % Margin | – | – | – | -392,207.8% |
| Net Income | -$1,949 | -$1,488 | -$9,802 | -$542 |
| % Margin | – | – | – | -703,896.1% |
| EPS Diluted | -0.002 | -0.002 | -0.02 | -0.002 |
| % Growth | 0% | 88.2% | -1,027.8% | – |
| Operating Cash Flow | -$206 | -$327 | -$751 | -$240 |
| Capital Expenditures | $0 | $0 | $0 | -$2 |
| Free Cash Flow | -$206 | -$327 | -$751 | -$242 |